TGFB1 and non-small cell lung carcinoma: Despite this, genistein treatment still reduced the proliferation of A549 non-small-cell lung carcinoma (NSCLC) cells [74] and impaired invasion, metastasis, and the progression of the EMT induced by transforming growth factor β1 (TGF-β1) in Panc-1 human pancreatic cancer cells [75].